I’m not sure, but you also have to add in the potential market to gain with NWBO’s technology holding as the base technology for many other adjuvants not only in solid tumor cancers but other diseases as well, including viral illnesses that could become the future as globalization continues to bring far stretches of the globe closer and closer.